Manus Raises £1.2M to Launch NeuroMotor Pen, Tool for Early Diagnosis

Manus Raises £1.2M to Launch NeuroMotor Pen, Tool for Early Diagnosis

284433

Manus Raises £1.2M to Launch NeuroMotor Pen, Tool for Early Diagnosis

Manus Neurodynamica, a medical technology company, has raised £1.2 million ($1.6 million) to launch NeuroMotor, a digital pen with a patented sensor technology that can help diagnose patients with Parkinson’s disease and other movement disorders. This financing round will allow the NeuroMotor Pen to be launched in the U.K. and Europe later this year, while the company works toward potential regulatory approval in the U.S. “We can finally look forward to seeing our NeuroMotor Pens…

You must be logged in to read/download the full post.